Biotech Masterclass: Managing Foreign Interference Risks Effectively
.png)
- 9 Jan 2026 9:00 AM
- 4 Feb 2026 5:00 PM
- Thursday 5 February 2026
- Log in now to register
Biotech Masterclass: Managing Foreign Interference Risks Effectively
AusBiotech, in partnership with the Department of Home Affairs’ Technology Foreign Interference Taskforce (TechFIT) and CSL, presents the ‘Biotech Masterclass: Managing Foreign Interference Risks Effectively’ — a bespoke event designed to support participants with practical knowledge and guidance to navigate foreign interference risks in a complex global environment.
This 3-hour workshop will feature:
- Practical guidance on key considerations when collaborating with, or receiving investment from, foreign partners.
- Interactive, worked case studies based on real-life scenarios.
- Morning tea.
The workshop will be followed by a networking lunch.
Event Details
Date: |
Thursday 5 February 2026 |
| spacing | spacing |
Time (AEDT): |
8:45AM - 9:00AM: Registration 9:00AM - 12:00PM: Workshop 12:00PM - 1:00PM: Networking Lunch |
| spacing | spacing |
Venue: |
Central Melbourne CBD Location to be advised on registration. IN-PERSON ONLY EVENT |
| spacing | spacing |
Cost: |
Free Please register with code 'AUSBIOTECH26' |
Event Partners
|
We are pleased to partner with the Technology Foreign Interference Taskforce (TechFIT) within the Department of Home Affairs. TechFIT brings together Australian Government and industry stakeholders to safeguard Australia’s technology, intellectual property, and innovations. More information about TechFIT can be found here: Technology Foreign Interference Taskforce |
 |
We are also pleased to partner with CSL. CSL are a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. |
Forgot your password? Click here to reset/assign a new password